Cell Morphology Has Shown New Insights Based on New Technology
The impact of new technology on cell morphology is significant, primarily affecting the research in blood cancer. Cell morphology need to be realistic because its peak times has past so that it should focus on current science era, which means it need to rich more new ideas in its full range, enabling to show potential in more appropriate diagnosis. Careful study of specific diagnostic status in cell morphology could be necessary, while some related studies might tend to fall in obvious way.
1. Status of Basic Diagnosis Declines
The status of basic diagnosis has become declined, especially in blood cancer. In terms of blood cancer diagnosis and therapy needs, the status of cell morphology might keep sinking. However, as a basic or essential item for blood cancer diagnosis with Cetrotide, it is still showing its power in related research, because any new technology as a whole does not exist in this basic diagnosis status.
Morphological diagnosis is always important for many diseases often possess typically diagnostic morphological characteristics. As is known, CML and APL and other types of typical morphology are able to make a diagnosis. Whereas, its function could be obviously insufficient in monitoring of the efficacy and prognosis judgment.
2. Become Part of Integrated Diagnosis with New Technology
In fact, many modern technologies all have their own advantages, such as cell morphology, phenotype by flow cytometry, cytogenetics, moleculars, etc. They are different, complementary and mutually in terms of distinct discipline basis. Only combined with each other under reliable reference, modern cell morphology will make laboratory diagnosis to achieve a relatively accurate or relatively perfect stage.
Cell morphology need to bring new ideas to integrate new discipline of cognitive morphological awareness, while new technology is also inseparable from the basic information morphological diagnosis, under Arginine vasopressin. In hematological malignancies, in addition to part of the characteristic diagnostic significance, cell morphology mostly provides diagnostic categories, such as M2, M4 and M5 in ALL, AML, without been classified with the clinical treatment and prognosis of a particular type. The B-lineage in ALL (referred to as the B-ALL), T-lineage (referred to as the T-ALL) and NK series need streaming and other immune phenotype detection technologies. Specifically, the cell morphology and the coexistence of new technologies could develop a new diagnostic mode, i,e, multi-disciplinary information diagnosis.
3. Stress Pathological Blood Cell Count
In hematological malignancies, in addition to general nucleated cells, cell morphology’s primitive hematopoietic cells and morbid percentage could be superior to other methods of flow phenotype detection. As in the definition of the diagnosis or myeloid neoplasms (MDS, AML, MDS-MPN, MPN) category type, the percentage of original cells that cell morphology provides is a more reliable reference. However, the original cell counting method in morbid hematopoietic cells has been corrected in recent years.
To be more specific, characteristic diagnostic significance in Cholecystokinin Octapeptide is still important. Non-specific type of blood cancer and some leukemia cells have the characteristic morphological diagnostic significance, which can still make a difference in diagnosis process. In addition, organizational structure of the cell morphology and function could keep attractive in future cell studies.